• Search
  • Basket
    You have no items in your basket

This webinar focuses on the transformation of science into solutions in healthcare presenting an overview of the main stages of the process and their challenges.

First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside will focus on the process of creating new medicines. From the identification of a novel idea to approval by regulatory authorities.

Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, will present CD3-Cistim’s strategy for the evaluation and execution of drug development projects.

CD3-Cistim is an investment fund and drug discovery centre which develops new drugs based on the innovative science from their partners. The company bridges the gap between innovative biomedical research from academic institutions or biotechs and the pharmaceutical industry.

This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.

  • Are you an ASTP Member?

  • Join ASTP

  • Register for From bench to bedside - BioMedical SIG